One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

This is the second installment in a series of stories exploring memory disorders in the Chippewa Valley. In today’s installment we look at two couples who are dealing with the realities of having a ...

Taking longer to enter the dream phase can disrupt the ability to consolidate memories and interfere with emotion regulation.

As research continues, those involved say this would be a game changer, especially for patients with very limited options.